• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (5081982)   Today's Articles (3)
For: Oxaliplatin combinations as first-line therapy in advanced colorectal cancer. Clin Colorectal Cancer 2002;2:78-80. [PMID: 12453320 DOI: 10.1016/s1533-0028(11)70508-4] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Number Cited by Other Article(s)
1
Maillard M, Le Louedec F, Thomas F, Chatelut E. Diversity of dose-individualization and therapeutic drug monitoring practices of platinum compounds: a review. Expert Opin Drug Metab Toxicol 2020;16:907-925. [PMID: 33016786 DOI: 10.1080/17425255.2020.1789590] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
2
Claassen YHM, van der Valk MJM, Breugom AJ, Frouws MA, Bastiaannet E, Liefers G, van de Velde CJH, Kapiteijn E, Cochrane Colorectal Cancer Group. Survival differences with immediate versus delayed chemotherapy for asymptomatic incurable metastatic colorectal cancer. Cochrane Database Syst Rev 2018;11:CD012326. [PMID: 30480771 PMCID: PMC6517244 DOI: 10.1002/14651858.cd012326.pub2] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA